Conversation with The Cancer Letter ACS’s Siegel: Large drop in lung cancer mortality likely driven by treatment, not just drugs February 07, 2020Vol.46 No.06By Matthew Bin Han Ong
Are drugs really driving the latest drop in lung cancer mortality?Looks like treatment is playing a role, experts say February 07, 2020Vol.46 No.06By Matthew Bin Han Ong
Surgeon General’s report notes lack of evidence on e-cigarettes in smoking cessation January 31, 2020Vol.46 No.5By Alexandria Carolan
SU2C initiatives aim to boost diversity in cancer trials January 31, 2020Vol.46 No.5By Alexandria Carolan
Conversation with The Cancer LetterFree Thomas Lynch lists his areas of emphasis at the Hutch:Solid tumors, immuno-oncology, big data, microbial involvement January 31, 2020Vol.46 No.5By Paul Goldberg
Free The price of smoking for a lifetime is lowest in the South, highest in the NortheastHere are the numbers January 24, 2020Vol.46 No.04By Alexandria Carolan
Conversation with The Cancer Letter Attorney: Moffitt has made a “very irresponsible decision”—Thomas Sellers “never was a participant” in China’s Thousand Talents Program January 24, 2020Vol.46 No.04By Matthew Bin Han Ong
Moffitt’s internal investigation: Scientists did not disclose funding from state-sponsored programs in China January 24, 2020Vol.46 No.04
Report describes offshore accounts held by Moffitt scientists involved in China’s Thousand Talents programLawyer for former director Thomas Sellers says it's "Nonsense," prepares defamation suit January 24, 2020Vol.46 No.04By Matthew Bin Han Ong
Turman named president of ACT for NIH, group credited with boosting research funding January 17, 2020Vol.46 No.03By Paul Goldberg
